Terms: = Brain cancer AND FOXO1, Q12778, FOXO1A, 2308, ENSG00000150907, FKH1, FKHR AND Treatment
15 results:
1. Epigenomic and transcriptomic landscaping unraveled candidate repositioned therapeutics for non-functioning pituitary neuroendocrine tumors.
Aydin B; Beklen H; Arga KY; Bayrakli F; Turanli B
J Endocrinol Invest; 2023 Apr; 46(4):727-747. PubMed ID: 36306107
[TBL] [Abstract] [Full Text] [Related]
2. Inhibition of glioblastoma progression by Urolithin A in vitro and in vivo by regulating Sirt1-foxo1 axis via ERK/AKT signaling pathways.
Liu CL; Zhao D; Li JJ; Liu S; An JJ; Wang D; Hu FA; Qiu CY; Cui MH
Neoplasma; 2022 Jan; 69(1):80-94. PubMed ID: 34818027
[TBL] [Abstract] [Full Text] [Related]
3. HBX-induced miR-5188 impairs foxo1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma.
Lin X; Zuo S; Luo R; Li Y; Yu G; Zou Y; Zhou Y; Liu Z; Liu Y; Hu Y; Xie Y; Fang W; Liu Z
Theranostics; 2019; 9(25):7583-7598. PubMed ID: 31695788
[TBL] [Abstract] [Full Text] [Related]
4. Identification of Potential Biomarkers with Diagnostic Value in Pituitary Adenomas Using Prediction Analysis for Microarrays Method.
Peng H; Deng Y; Wang L; Cheng Y; Xu Y; Liao J; Wu H
J Mol Neurosci; 2019 Nov; 69(3):399-410. PubMed ID: 31280474
[TBL] [Abstract] [Full Text] [Related]
5. miR-374a Inhibitor Enhances Etoposide-Induced Cytotoxicity Against Glioma Cells Through Upregulation of foxo1.
Ni W; Luo L; Zuo P; Li R; Xu X; Wen F; Hu D
Oncol Res; 2019 Jun; 27(6):703-712. PubMed ID: 30841958
[TBL] [Abstract] [Full Text] [Related]
6. foxo1 associated with sensitivity to chemotherapy drugs and glial-mesenchymal transition in glioma.
Chen C; Han G; Li Y; Yue Z; Wang L; Liu J
J Cell Biochem; 2019 Jan; 120(1):882-893. PubMed ID: 30216501
[TBL] [Abstract] [Full Text] [Related]
7. FoxG1 facilitates proliferation and inhibits differentiation by downregulating FoxO/Smad signaling in glioblastoma.
Wang L; Wang J; Jin T; Zhou Y; Chen Q
Biochem Biophys Res Commun; 2018 Sep; 504(1):46-53. PubMed ID: 30172378
[TBL] [Abstract] [Full Text] [Related]
8. Candidate genes and microRNAs for glioma pathogenesis and prognosis based on gene expression profiles.
Xie C; Xu M; Lu D; Zhang W; Wang L; Wang H; Li J; Ren F; Wang C
Mol Med Rep; 2018 Sep; 18(3):2715-2723. PubMed ID: 30015885
[TBL] [Abstract] [Full Text] [Related]
9. NS1619 regulates the expression of caveolin-1 protein in a time-dependent manner via ROS/PI3K/PKB/foxo1 signaling pathway in brain tumor microvascular endothelial cells.
Cai RP; Xue YX; Huang J; Wang JH; Wang JH; Zhao SY; Guan TT; Zhang Z; Gu YT
J Neurol Sci; 2016 Oct; 369():109-118. PubMed ID: 27653874
[TBL] [Abstract] [Full Text] [Related]
10. FoxO proteins or loss of functional p53 maintain stemness of glioblastoma stem cells and survival after ionizing radiation plus PI3K/mTOR inhibition.
Firat E; Niedermann G
Oncotarget; 2016 Aug; 7(34):54883-54896. PubMed ID: 27448972
[TBL] [Abstract] [Full Text] [Related]
11. HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma.
Pei Y; Liu KW; Wang J; Garancher A; Tao R; Esparza LA; Maier DL; Udaka YT; Murad N; Morrissy S; Seker-Cin H; Brabetz S; Qi L; Kogiso M; Schubert S; Olson JM; Cho YJ; Li XN; Crawford JR; Levy ML; Kool M; Pfister SM; Taylor MD; Wechsler-Reya RJ
Cancer Cell; 2016 Mar; 29(3):311-323. PubMed ID: 26977882
[TBL] [Abstract] [Full Text] [Related]
12. Cranial metastatic alveolar rhabdomyosarcoma mimicking hematological malignancy in an adolescent boy.
Patiroglu T; Isik B; Unal E; Canoz O; Deniz K; Kosemehmetoglu K; Karakukcu M; Ozdemir MA
Childs Nerv Syst; 2014 Oct; 30(10):1737-41. PubMed ID: 24917491
[TBL] [Abstract] [Full Text] [Related]
13. Rapidly progressive congenital rhabdomyosarcoma presenting with multiple cutaneous lesions: an uncommon diagnosis and a therapeutic challenge.
Rekhi B; Qureshi SS; Narula G; Gujral S; Kurkure P
Pathol Res Pract; 2014 May; 210(5):328-33. PubMed ID: 24635971
[TBL] [Abstract] [Full Text] [Related]
14. Angiotensin-(1-7): beyond the cardio-renal actions.
Passos-Silva DG; Verano-Braga T; Santos RA
Clin Sci (Lond); 2013 Apr; 124(7):443-56. PubMed ID: 23249272
[TBL] [Abstract] [Full Text] [Related]
15. Selenoprotein P expression is controlled through interaction of the coactivator PGC-1alpha with foxo1a and hepatocyte nuclear factor 4alpha transcription factors.
Speckmann B; Walter PL; Alili L; Reinehr R; Sies H; Klotz LO; Steinbrenner H
Hepatology; 2008 Dec; 48(6):1998-2006. PubMed ID: 18972406
[TBL] [Abstract] [Full Text] [Related]
